Johnson & Johnson (NYSE:JNJ)

Data as of Nov 21
 -0.32 / -0.30%
Today’s Change
Today|||52-Week Range
Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
10:19am /
AstraZeneca/Amgen's Brodalumab Positive in Psoriasis Trial - Analyst Blog
Nov 13 /
3 Steps You Should Immediately Take to Be a Better Investor
9:45am /
This Billion Dollar Fund Manager is Betting Big on IBM Stock
Nov 13 /
3 Healthcare Stocks Short-Sellers Are Wrong About
Nov 21 /
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Nov 12 /
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog
Nov 20 /
Pandering Your Wealth Away
Nov 12 /
Riding The Bull Market With These 2 Momentum ETFs
Nov 20 / Benzinga
Should Johnson & Johnson Buy Medivation Inc.?
Nov 12 /
Does Johnson & Johnson Still Fit With Warren Buffett's Investing Strategy?
Nov 20 /
Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Nov 11 /
Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow
Nov 20 /
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog
Nov 11 /
Top 25 S.A.F.E. Dividend Stocks
Nov 20 /
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Nov 11 /
Alibaba Group Holding Ltd (BABA): Why The Stock Is Still A Buy
Nov 19 / Investing Channel
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Nov 10 /
3 Dividend Stocks for a Stock Market Crash
Nov 18 /
4 Stocks to Look at via Ebola Crisis - Analyst Blog
Nov 10 /
Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Nov 17 /
3 Stocks for the Next 100 Years
Nov 10 /
Johnson & Johnson, WuXi PharmaTech (Cayman) Inc. (ADR): Aging Chinese Population Crea...
Nov 17 / Investing Channel
October jitters are just a taste things to come
Nov 10 /
Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More
Nov 17 /
US earnings boost masks revenue fears
Nov 07 /
5 Rocket Stocks to Buy as Earnings Season Ends
Nov 17 /
20 Largest U.S. Companies By Market Capitalization
Nov 05 /
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 /
AstraZeneca strikes deals on cancer drugs
Nov 04 /
Forget Marijuana! This Is a Much Smarter Investment
Nov 16 /
Ebola: The making of a $1 billion drug
Oct 28 /
3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Su...
Nov 15 /
Why it could pay to bet against consensus on Europe
Oct 24 /
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Nov 14 /
Progress against Aids spurs GSK plan to float ViiV Healthcare
Oct 24 /
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Nov 14 /
Big pharma battles charge of tardiness on Ebola
Oct 24 /

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.